| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 204 |
| 1 | METHOTREXATE SODIUM | 76 |
| 2 | METHOTREXATE | 61 |
| 3 | CYTARABINE | 52 |
| 4 | DEXAMETHASONE | 46 |
| 5 | DEXAMETHASONE 1.5 MG | 46 |
| 6 | CYCLOPHOSPHAMIDE | 39 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 39 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 39 |
| 9 | DASATINIB | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 204 | 0.0190 |
| 1 | INOTUZUMAB OZOGAMICIN | 15 | 0.0050 |
| 2 | PONATINIB HYDROCHLORIDE | 22 | 0.0042 |
| 3 | DASATINIB | 28 | 0.0030 |
| 4 | GILTERITINIB | 12 | 0.0029 |
| 5 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 6 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 7 | QUIZARTINIB | 1 | 0.0014 |
| 8 | ARSENIC TRIOXIDE | 3 | 0.0013 |
| 9 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 91 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 68 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 61 |
| 3 | Alkylating Drug [EPC] | 43 |
| 4 | Kinase Inhibitor [EPC] | 19 |
| 5 | Leukocyte Growth Factor [EPC] | 18 |
| 6 | Azole Antifungal [EPC] | 17 |
| 7 | BCL-2 Inhibitor [EPC] | 17 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 9 | CD22-directed Immunoconjugate [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 15 | 0.0050 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 2 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 3 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 4 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 6 | Asparagine-specific Enzyme [EPC] | 6 | 0.0004 |
| 7 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 9 | BCL-2 Inhibitor [EPC] | 17 | 0.0003 |